Clinical Trials Browser

Phase 2/3 × masitinib × Gynecologic × Clear all

NCT02490488 2020-12-08

Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients

Phase 2/3 Completed

Ovarian Neoplasms